Literature DB >> 3092526

The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone.

L Wide.   

Abstract

The relationship between charge on human FSH (hFSH) molecules and their metabolic clearance rate (MCR) was investigated. The median charge of the hFSH molecules was expressed as their median mobility at electrophoresis in 0.075 M sodium veronal buffer, pH 8.6. MCR was estimated after single iv injection in mice of unfractionated and fractionated extracts of human pituitaries. There was a highly significant (P less than 0.001) correlation between charge and MCR both for forms of FSH present within the individual pituitary and for FSH in different pituitaries. After the iv injection there was a gradual change to a more negative median charge of hFSH in plasma. This was explained by the more rapid clearance of the less negatively charged forms of hFSH and thus selective survival of different forms in the circulation. This is a most likely explanation for the differences in median charge between FSH in pituitaries and in sera of men and women of corresponding age. The results suggest that MCR of human FSH is controlled by a gonadal-pituitary feed-back mechanism which involves changes in the structure of the FSH produced by the pituitary. It is suggested that charge is one factor involved in the regulation of the survival of FSH in the circulation and that this is of physiological importance for the control of the ovarian function during the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092526     DOI: 10.1530/acta.0.1120336

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  7 in total

1.  Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.

Authors:  Arianna Pacchiarotti; Cesare Aragona; Renzo Gaglione; Helmy Selman
Journal:  J Assist Reprod Genet       Date:  2007-07-26       Impact factor: 3.412

2.  Macro- and Micro-heterogeneity in Pituitary and Urinary Follicle-Stimulating Hormone Glycosylation.

Authors:  George R Bousfield; Vladimir Y Butnev; Monica A Rueda-Santos; Alan Brown; Aaron Smalter Hall; David J Harvey
Journal:  J Glycomics Lipidomics       Date:  2014

3.  Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.

Authors:  F A Fares; N Suganuma; K Nishimori; P S LaPolt; A J Hsueh; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women.

Authors:  Leif Wide; Karin Eriksson; Patrick M Sluss; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2008-12-30       Impact factor: 5.958

5.  Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence.

Authors:  Fuad Fares; Avri Havron; Eyal Fima
Journal:  Int J Cell Biol       Date:  2011-08-21

6.  Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants.

Authors:  John S Davis; T Rajendra Kumar; Jeffrey V May; George R Bousfield
Journal:  J Glycomics Lipidomics       Date:  2014

Review 7.  Profile of follitropin alpha/lutropin alpha combination for the stimulation of follicular development in women with severe luteinizing hormone and follicle-stimulating hormone deficiency.

Authors:  Leonardo Rinaldi; Helmy Selman
Journal:  Int J Womens Health       Date:  2016-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.